High throughput Characterization of KCNB1 variants Associated with Developmental and Epileptic Encephalopathy
Seok Kyu KangiD, Carlos G. VanoyeiD, Sunita N. MisraiD, Dennis M. Echevarria-CooperiD, Jeffrey Dennis CalhouniD, John B. O'Connor, Katarina L. FabreiD, Dianalee McKnightiD, Laurie DemmeriD, Paula C. Goldenberg, Lauren E. Grote, Isabelle ThiffaultiD, Carol SaundersiD, Kevin A. StraussiD, Ali TorkamaniiD, Jasper J. van der SmagtiD, Koen L.I. van GasseniD, Robert P. CarsoniD, Jullianne DiaziD, Eyby L. LeoniD, Joseph E. JacheriD, Mark HannibaliD, Jessica Litwin, Neil FriedmaniD, Allison Schreiber, , Jennifer A. KearneyiD
Abstract
Pathogenic variants in KCNB1, encoding the voltage-gated potassium channel Kv2.1, are associated with developmental and epileptic encephalopathies (DEE). Previous functional studies on a limited number of KCNB1 variants indicated a range of molecular mechanisms by which variants affect channel function, including loss of voltage sensitivity, loss of ion selectivity, and reduced cell-surface expression. We evaluated a series of 17 KCNB1 variants associated with DEE or neurodevelopmental disorder (NDD) to rapidly ascertain channel dysfunction using high-throughput functional assays. Specifically, we investigated the biophysical properties and cell-surface expression of variant Kv2.1 channels expressed in heterologous cells using high-throughput automated electrophysiology and immunocytochemistry-flow cytometry. Pathogenic variants exhibited diverse functional defects, including altered current density and shifts in the voltage-dependence of activation and/or inactivation, as homotetramers or when co-expressed with wild-type Kv2.1. Quantification of protein expression also identified variants with reduced total Kv2.1 expression or deficient cell-surface expression.\n\nOur study establishes a platform for rapid screening of functional defects of KCNB1 variants associated with DEE and other NDDs, which will aid in establishing KCNB1 variant pathogenicity and may enable discovery of targeted strategies for therapeutic intervention based on molecular phenotype.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 62
- FWCI
- 2.81
- Field percentile
- top 8%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epilepsy and neurobehavioral abnormalities in mice with a KCNB1 pathogenic variant that alters conducting and non-conducting functions of KV2.1
Nicole A. Hawkins, Sunita N. Misra, … Jennifer A. Kearney·Neurobiology of DiseasePeer-reviewed·Oct 23, 2020
- KCNH1 variants associated with neurodevelopmental disorders exhibit prominent gain-of-function
Christopher H. Thompson, Christine Q. Simmons, … Alfred L. George·BrainPeer-reviewed·Oct 27, 2026
- High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity
Carlos G. Vanoye, Reshma R. Desai, … Alfred L. George·JCI InsightPeer-reviewed·Feb 1, 2022
- Epilepsy-causing KCNT1 variants increase KNa1.1 channel activity by disrupting the activation gate.
Bethan A. Cole, Nadia Pilati, Jonathan D. Lippiat·bioRxiv·Sep 16, 2021
- Molecular dynamics of the pathogenic KCNQ2 variant G256W reveal mechanisms of channel dysfunction in epileptic encephalopathy
Emma C. Thompson, Edward C. Cooper, Bill R. Miller·Journal of Biomolecular Structure and DynamicsPeer-reviewed·Feb 11, 2026
- High-throughput functional mapping of variants in an arrhythmia gene, KCNE1, reveals novel biology
Ayesha Muhammad, Maria E. Calandranis, … Andrew Michael Glazer·bioRxiv·Apr 28, 2023